Neurocrine Biosciences, Inc. (NBIX)
132.39
-0.96
(-0.72%)
USD |
NASDAQ |
Jan 16, 16:00
131.71
-0.68
(-0.51%)
After-Hours: 06:16
Neurocrine Biosciences Market Cap: 13.20B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.84B |
| Masimo Corp. | 7.630B |
| Insulet Corp. | 20.24B |
| Marker Therapeutics, Inc. | 30.18M |
| CapsoVision, Inc. | 291.83M |
Market Cap Related Metrics
| PE Ratio | 31.62 |
| PS Ratio | 5.045 |
| PEG Ratio | 2.597 |
| Price to Book Value | 4.395 |
| Price to Free Cash Flow | 22.82 |
| Price | 132.39 |
| Earnings Yield | 3.16% |
| PEGY Ratio | 2.597 |
| Operating PE Ratio | 24.45 |
| Normalized PE Ratio | 31.01 |